May 19, 2022

Dubai Week

Complete Dubai News World

Reveals promising data on increased levels of the modern corona vaccine .. Will it cure Omigron mutation?

Reveals promising data on increased levels of the modern corona vaccine .. Will it cure Omigron mutation?

Dubai, United Arab Emirates (CNN) – Modern Biotechnology announced on Monday that its booster dose and half-dose increase the level of antibodies against the mutated corona virus “Omigron”. High doses increase antibody levels.

Currently, the booster dose of the modern vaccine is 50 mcg. The company reported that the dose increased antibody levels 37-fold compared to what was seen when a fully vaccinated person did not receive a booster dose, while the 100-mcg booster dose increased antibody level 83-fold.

It is not clear what these increases mean in terms of how effective booster doses are clinically against Omigran strain.

But in the company’s report, CEO Stephen Bonsell confirms the data.

“The massive increase in COVID-19 infections caused by OMICRON mutants is of great concern to everyone,” Bancel said. “However, these data show that the booster dose of the currently approved COVID-19 moderna vaccine increases the level of neutralizing antibody by 37 times. It promises to be higher than the pre – booster level.”

“Moderna will continue to introduce a possible booster dose of Omicron in clinical trials in response to this highly contagious strain, if necessary in the future. We will continue to generate and share data with public health officials through our support strategies to make evidence-based decisions about the best SARS-CoV-2 vaccine strategies. Help them “.

SARS-CoV-2 is the name of a growing corona virus that causes COV-19.

For his part, the company’s president, Dr. Stephen Hawk, pointed out on Monday that the U.S. public health authorities should now consider whether the booster dose of the modern vaccine against the corona virus should be overdosed.

See also  Thank you to everyone who contributed to the success of the Expo

“The decision to use 100 micrograms or more is a decision for public health organizations at this point,” Hawk said during a company conference call. “We provide the data. Obviously we’re going to share it. Everyone can make that decision.”

Moderna spokeswoman Colin Hussey confirmed to CNN in an email statement Monday that the company “shares data with regulators when they begin evaluating whether to make any changes to approved booster doses.”

The report states that the booster dose of the modern corona virus modern vaccine is approved for emergencies in the United States and that they are given in half doses of 50 micrograms and 100 micrograms. It is allowed to give to people with severe immune deficiency.

According to data from the U.S. Centers for Disease Control and Prevention, approximately 32% or about 60 million people who are fully vaccinated have a booster, and more than 26.7 million of them have a modern booster.

Separately, Hawk, the company’s president, confirmed on Monday that Moderna would continue to push an Omigron booster into clinical trials in early 2022.

For his part, Dr. Anthony Fassi, director of the National Institute of Allergy and Infectious Diseases, said last week that booster doses of the Kovit-19 vaccine could help improve protection against the “Omigron” corona virus strain. A booster dose dedicated to mutants. Currently new.